LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis
Europe - FRA:LIK - DE000A0JDBC7 - Common Stock
364 EUR
+10 (+2.82%)
Taking everything into account, LIK scores 6 out of 10 in our fundamental rating. LIK was compared to 29 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making LIK a very profitable company, without any liquidiy or solvency issues. LIK is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make LIK a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year LIK was profitable.
LIK had positive earnings in 4 of the past 5 years.
In multiple years LIK reported negative operating cash flow during the last 5 years.
1.2 Ratios
LIK's Return On Assets of 10.51% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
LIK has a better Return On Equity (20.85%) than 89.66% of its industry peers.
LIK has a Return On Invested Capital of 15.26%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LIK is significantly above the industry average of 6.09%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROIC | 15.26% |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
1.3 Margins
LIK has a Profit Margin of 10.81%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
LIK's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 16.42%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of LIK has declined.
LIK's Gross Margin of 95.03% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of LIK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% |
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIK is creating value.
Compared to 1 year ago, LIK has about the same amount of shares outstanding.
The number of shares outstanding for LIK remains at a similar level compared to 5 years ago.
Compared to 1 year ago, LIK has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.19 indicates that LIK is not in any danger for bankruptcy at the moment.
LIK has a Altman-Z score of 5.19. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
LIK has a Debt/Equity ratio of 0.56. This is a neutral value indicating LIK is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.56, LIK belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.19 |
ROIC/WACC2.2
WACC6.94%
2.3 Liquidity
A Current Ratio of 3.25 indicates that LIK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.25, LIK belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
LIK has a Quick Ratio of 3.23. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.23, LIK belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.76% over the past year.
Measured over the past years, LIK shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.60% on average per year.
Looking at the last year, LIK shows a decrease in Revenue. The Revenue has decreased by -0.13% in the last year.
The Revenue has been growing by 35.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
3.2 Future
LIK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.77% yearly.
Based on estimates for the next years, LIK will show a very strong growth in Revenue. The Revenue will grow by 23.59% on average per year.
EPS Next Y55.18%
EPS Next 2Y36.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.32%
Revenue Next 2Y23.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LIK is valuated rather expensively with a Price/Earnings ratio of 23.23.
Based on the Price/Earnings ratio, LIK is valued a bit more expensive than 62.07% of the companies in the same industry.
LIK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.32.
LIK is valuated reasonably with a Price/Forward Earnings ratio of 10.98.
65.52% of the companies in the same industry are more expensive than LIK, based on the Price/Forward Earnings ratio.
LIK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.23 | ||
| Fwd PE | 10.98 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIK is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.66 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LIK has a very decent profitability rating, which may justify a higher PE ratio.
LIK's earnings are expected to grow with 36.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y36.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
LIK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LIK (9/26/2025, 7:00:00 PM)
364
+10 (+2.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap105.56M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.23 | ||
| Fwd PE | 10.98 | ||
| P/S | 2.48 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.79 | ||
| P/tB | 7.51 | ||
| EV/EBITDA | 10.66 |
EPS(TTM)15.67
EY4.3%
EPS(NY)33.14
Fwd EY9.11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS146.68
BVpS76.04
TBVpS48.46
PEG (NY)0.42
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROCE | 18.69% | ||
| ROIC | 15.26% | ||
| ROICexc | 21.72% | ||
| ROICexgc | 31.24% | ||
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% | ||
| FCFM | N/A |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
ROICexc(3y)23.25%
ROICexc(5y)N/A
ROICexgc(3y)57.5%
ROICexgc(5y)N/A
ROCE(3y)18.77%
ROCE(5y)N/A
ROICexcg growth 3Y-31.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-14.79%
ROICexc growth 5YN/A
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
F-ScoreN/A
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | 5.19 |
F-ScoreN/A
WACC6.94%
ROIC/WACC2.2
Cap/Depr(3y)160.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
EPS Next Y55.18%
EPS Next 2Y36.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
Revenue Next Year29.32%
Revenue Next 2Y23.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.44%
EBIT growth 3Y-1.81%
EBIT growth 5YN/A
EBIT Next Year99.7%
EBIT Next 3Y40.47%
EBIT Next 5Y29.34%
FCF growth 1Y890.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3YN/A
OCF growth 5YN/A